ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Merck writes off big bet on CETP drug anacetrapib
October 13, 2017Merck, the last big firm standing in the once-hyped CETP field, has opted against filing for approval of anacetrapib. The Big Pharma reached the decision after going over a mixed set of data from its big bet on a phase 3 program. -
MSD pulls plug on cholesterol drug anacetrapib
October 13, 2017MSD has decided to pull the plug on its late-stage cholesterol drug anacetrapib after a lacklustre performance in clinical trials. -
Anacetrapib reduces risk of serious cardiovascular events
August 30, 2017An international clinical trial has assessed the efficacy and safety of adding anacetrapib versus placebo atorvastatin in patients with vascular diseases… -
Merck's anacetrapib meets primary endpoint
June 30, 2017Company to consider whether to file new drug applications with the FDA and other regulatory agencies.
Pharma Sources Insight January 2025
